Please visit answersincme.com/TVT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in endocrinology discusses how to optimize the use of novel non-steroidal mineralocorticoid receptor antagonists (MRAs) for patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). Upon completion of this activity, participants should be better able to: Evaluate the clinical impact of the latest safety and efficacy data for novel non-steroidal MRAs in patients with CKD and T2D; Identify patients with CKD and T2D who might benefit from treatment with novel non-steroidal MRAs; and Formulate treatment plans for patients with CKD and T2D that incorporate the latest evidence and guideline updates for non-steroidal MRAs.